by Naniche D, Hotez P, Bottazzi ME, Ergonul O, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow D, Kim JH, Lall B, Larson H, Sheahan T, Shoham S, Wilder-Smith A, Sow SO, Strub-Wourgaft N, Yadav P, Batista C. EClinicalMedicine 2021; 36:100925. doi: 10.1016/j.eclinm.2021.100925
Summary: Vaccine roll-out requires robust pharmacovigilance systems and global coordination of post-licensure surveillance, coupled with sophisticated communication strategies and efforts to combat vaccine misinformation. There are challenges to ensuring alignment, transparency and interconnectivity across different systems and rapid feedback from national to global levels. It is unclear how countries will collect, analyze and share real-world safety and effectiveness data for subsequent decision-making. It should be stressed to stakeholders, including governments, ministries of health and international funders that investment in halting the COVID-19 pandemic does not stop at mass immunization. The timely generation and dissemination of post-vaccination safety data will inform data-driven policies, promote vaccine confidence, and accelerate the establishment of herd immunity necessary to end this pandemic.
